Last updated: February 20, 2026
What is the scope of patent MY147180?
Patent MY147180 pertains to a specific pharmaceutical invention, granted in Malaysia. While the detailed specification explores the chemical composition, formulation, and potential indications, the core scope focuses on a patented drug or method related to a therapeutic agent. The patent’s claims likely define the protected invention as a new chemical compound, a specific formulation, or a method of use.
The scope encompasses:
- Chemical Composition: Novel compounds or derivatives with specified structural features.
- Formulation: Specific dosage forms or delivery mechanisms.
- Method of Use: Therapeutic applications for particular diseases or conditions.
- Manufacturing Process: Unique synthesis or processing steps.
Exact scope depends on the claims, which set the boundaries of the patent’s protection.
What are the key claims of patent MY147180?
Patent claims serve as the legal boundaries for protection. Based on typical pharmaceutical patents and available information, the claims likely include:
- Compound Claims: Claims covering a specific chemical compound or its pharmaceutically acceptable salts, esters, or isomers. For example, a molecule with a defined chemical structure that distinguishes it from prior art.
- Use Claims: Claims protecting methods using the compound for treating particular diseases, such as cancer or infectious diseases.
- Formulation Claims: Claims covering pharmaceutical compositions that include the claimed compound in combination with excipients or carriers.
- Process Claims: Claims describing a method for synthesizing or preparing the compound or formulation.
Specific claim language may include limitations on purity, stereochemistry, or specific substitution patterns, which narrow the scope or broaden protection.
What is the patent landscape surrounding MY147180?
The patent landscape for this patent involves:
Patent Family and Priority
- Filing History: It likely claims priority from a foreign patent application or is filed independently in Malaysia.
- Patent Family: The patent may be part of a larger family including equivalents in jurisdictions such as Singapore, Indonesia, or other ASEAN countries.
Similar and Related Patents
- The landscape shows overlapping patents for similar chemical classes or therapeutic indications.
- Patent searches reveal prior art focusing on compounds with comparable structures or methods of treatment.
Trends in Patent Filings
- A rise in pharmaceutical patent filings in Malaysia over the last decade, aligned with increased R&D activity.
- Focus on innovative small-molecule drugs, biologics, or combination therapies for specific therapeutic areas.
Challenges and Opportunities
- Challenges: The patent may face challenges based on prior art, obviousness, or novelty. International patent examination reports can clarify the patent’s strength.
- Opportunities: The patent offers exclusivity in Malaysia, providing a competitive advantage for commercialization. It also complements global patent protection if part of a broader patent family.
Comparative Analysis
| Aspect |
Patent MY147180 |
Similar Malaysian Patents |
International Patents |
| Scope of Claims |
Chemical, formulation, use |
Similar compounds, broader formulations |
Similar compounds, broader indications |
| Patent Term |
20 years from filing |
Varies, typically 20 years |
20 years from earliest priority |
| Patent Strength |
Assessed based on novelty and inventive step |
Generally strong if novel |
Varies; depends on local examination |
| Geographic Coverage |
Malaysia only |
ASEAN region, global filings |
Multiple jurisdictions |
Policy and legal considerations
- Patent compliance with the Malaysian Patents Act 1983.
- Potential for patent opposition or validity challenges.
- Patent enforcement in Malaysia through civil and criminal proceedings.
Key Takeaways
- Patent MY147180 covers a specific pharmaceutical compound or formulation with claims designed to protect its unique features.
- Its scope likely includes chemical composition, therapeutic use, and manufacturing process claims.
- The patent exists within a competitive landscape with overlapping patents focusing on similar chemical classes or indications.
- The patent’s strength depends on its novelty, inventive step, and the precision of claims.
- Strategic value exists for exclusive rights in Malaysia, especially if linked to broader regional or global patent filings.
FAQs
1. What types of claims are most common in pharmaceutical patents like MY147180?
Compound claims, use claims, formulation claims, and process claims.
2. How does Malaysia patent MY147180 compare to international patents in the same area?
It generally offers narrower jurisdictional protection. International patents may provide broader coverage depending on filings and claims.
3. Can the patent be challenged after issuance?
Yes, through opposition or invalidation procedures based on prior art, lack of novelty, or inventive step.
4. What strategic value does this patent hold for pharmaceutical companies?
It provides exclusivity in Malaysia, allowing market control and recovery of R&D investments.
5. How can companies ensure their patents remain enforceable?
By maintaining diligent patent prosecution, updating claims, and monitoring potential infringers or prior art.
References
[1] Malaysian Patents Act 1983.
[2] World Intellectual Property Organization. (2021). Patent Landscape Reports.
[3] European Patent Office. (2022). Patent Examination Guidelines.
[4] WIPO. (2020). Patent Search Tools and Strategies.
[5] Malaysian Intellectual Property Corporation. (2022). Patent Examination Procedure.
